Obesity: A preventable, treatable, but relapsing disease
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
In 2013, the American Medical Association recognized obesity as a disease, of growing scientific, social, and political interest. In 2016 in the United States, prevalence rates of preobesity and obesity exceeded 60%. In Italy, these rates exceeded 40%. Total costs related to excess weight reached 9.3% of the U.S. gross domestic product, whereas in Italy the total annual cost of diabetes alone was estimated at 20.3 billion euros/y. The expansion of adipose tissue and visceral fat causes compression, joint stress, metabolic disorders, organ dysfunction, and increased mortality. The increase in peripheral and central fat mass is a chronic and potentially reversible process with appropriate diagnosis and treatment. Conversely, fattening can turn into a chronic relapsing form, complicated by comorbidities and cardiovascular events. The increased risk for mortality and morbidity also can affect metabolically healthy obese individuals, if the condition is underestimated, with disease progression. Due to its inaccuracy, body mass index must be replaced with body composition for the diagnosis of obesity. The chances of obesity reversibility are closely linked to improving the diagnosis and to timely nutritional interventions. Generalization and stigma hinder the treatment of obese individuals. The recognition of obesity as a disease and institutional interest can shift the focus onto obesity and not on the obese, with improvements in adherence to prevention plans. Anthropogenic factors and gut microbiota can influence human behavior and food choice, such as food addiction. Obesity has all the criteria to be recognized as a disease. Proper clinical management will lead to cost and complications savings, such as in diabetes. The aim of this review was to discuss in detail the criteria for defining primary obesity as a disease in a step-by-step manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Afshin, A., Sur, P. J., Fay, K. A., Cornaby, L., Ferrara, G., Salama, J. S., Mullany, E. C., Abate, K. H., Abbafati, C., Abebe, Z., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30041-8 · Cited by 5,811
Mechanisms, Pathophysiology, and Management of Obesity
Heymsfield, S. B., & Wadden, T. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1514009 · Cited by 1,867
Bray, G. A., Kim, K. K., Wilding, J. P. H., & on behalf of the World Obesity Federation (2017) · Obesity Reviews · doi:10.1111/obr.12551 · Cited by 1,612
Lean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017
Obesity as a Disease: The Obesity Society 2018 Position Statement
Jastreboff, A. M., Kotz, C. M., Kahan, S., Kelly, A. S., & Heymsfield, S. B. (2019) · Obesity · doi:10.1002/oby.22378 · Cited by 457
Regarding Obesity as a Disease
Kyle, T. K., Dhurandhar, E. J., & Allison, D. B. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.04.004 · Cited by 333
Food Cues and Obesity: Overpowering Hormones and Energy Balance Regulation
Belfort-DeAguiar, R., & Seo, D. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0303-1 · Cited by 84
De Lorenzo, A., Noce, A., Moriconi, E., Rampello, T., Marrone, G., Di Daniele, N., & Rovella, V. (2018) · Nutrients · doi:10.3390/nu10040474 · Cited by 68
Self-citation
Research works printed but not linked: 63
- Demongeot, 2016, Discrete dynamics of contagious social diseases: Example of obesity, Virulence, 7, 129, 10.1080/21505594.2015.1082708 · doi:10.1080/21505594.2015.1082708
- Hofmann, 2016, Obesity as a socially defined disease: philosophical considerations and implications for policy and care, Health Care Anal, 24, 86, 10.1007/s10728-015-0291-1 · DOI
- 2017, Should we officially recognise obesity as a disease?, Lancet Diabetes Endocrinol, 5, 483, 10.1016/S2213-8587(17)30191-2 · DOI
- Żukiewicz-Sobczak, 2014, Obesity and poverty paradox in developed countries, Ann Agric Environ Med, 21, 590, 10.5604/12321966.1120608 · DOI
- Daneschvar, 2016, FDA-approved anti-obesity drugs in the United States, Am J Med, 129, 10.1016/j.amjmed.2016.02.009 · DOI · Paper page
- Molfino, 2010, Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism, JPEN J Parenter Enteral Nutr, 34, 295, 10.1177/0148607109353440 · DOI
- Laviano, 2013, Sarcopenia and chemotherapy dosing in obese patients, Nat Rev Clin Oncol, 10, 664, 10.1038/nrclinonc.2013.108-c1 · DOI
- Kim, 2016, Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis, Value Health, 19, 602, 10.1016/j.jval.2016.02.008 · DOI · Paper page
- Costa de Miranda, 2018, Secular trend of childhood nutritional status in Calabria (Italy) and the United States: the spread of obesity, Nutr Res, 62, 23, 10.1016/j.nutres.2018.10.008 · DOI
- Atella, 2015, Excess body weight increases the burden of age-associated chronic diseases and their associated health care expenditures, Aging (Albany NY), 7, 882, 10.18632/aging.100833 · DOI
- De Lorenzo, 2019, Developing and cross-validation of new equations to estimate fat mass in Italian population, Eur Rev Med Pharmacol Sci, 23, 2513
- Marcellusi, 2016, The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach, Eur J Health Econ, 17, 139, 10.1007/s10198-014-0660-y · DOI
- Correia, 2018, Cost-effectiveness of nutrition therapy, Nutrition, 50, 109, 10.1016/j.nut.2018.01.001 · DOI
- Bays, 2008, Is adiposopathy (sick fat) an endocrine disease?, Int J Clin Pract, 62, 1474, 10.1111/j.1742-1241.2008.01848.x · DOI · Paper page
- King, 2013, Obesity & osteoarthritis, Indian J Med Res, 138, 185
- Ertunc, 2016, Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment, J Lipid Res, 57, 2099, 10.1194/jlr.R066514 · DOI · Paper page
- Mendez-Sanchez, 2018, New aspects of lipotoxicity in nonalcoholic steatohepatitis, Int J Mol Sci, 19, E2034, 10.3390/ijms19072034 · DOI · Paper page
- Wende, 2012, Mechanisms of lipotoxicity in the cardiovascular system, Curr Hypertens Rep, 14, 517, 10.1007/s11906-012-0307-2 · DOI · Paper page
- Halade, 2017, Obesity and cardiometabolic defects in heart failure pathology, Compr Physiol, 7, 1463, 10.1002/j.2040-4603.2017.tb00788.x · doi:10.1002/j.2040-4603.2017.tb00788.x
- Psaltopoulou, 2010, The role of diet and lifestyle in primary, secondary, and tertiary diabetes prevention: a review of meta-analyses, Rev Diabet Stud, 7, 26, 10.1900/RDS.2010.7.26 · DOI · Paper page
- Hughes, 2014, Timing of adiposity rebound and adiposity in adolescence, Pediatrics, 134, e1354, 10.1542/peds.2014-1908 · DOI
- Koyama, 2014, Adiposity rebound and the development of metabolic syndrome, Pediatrics, 133, e114, 10.1542/peds.2013-0966 · DOI
- Hinney, 2010, From monogenic to polygenic obesity: recent advances, Eur Child Adolesc Psychiatry, 19, 297, 10.1007/s00787-010-0096-6 · DOI · Paper page
- Mozaffarian, 2018, Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program(SNAP): a microsimulation study, PLoS Med, 15, 10.1371/journal.pmed.1002661 · DOI · Paper page
- Petrakis, 2017, Endocrine disruptors leading to obesity and related diseases, Int J Environ Res Public Health, 14, E1282, 10.3390/ijerph14101282 · DOI · Paper page
- Wang, 2016, Obesity reduces cognitive and motor functions across the lifespan, Neural Plast, 10.1155/2016/2473081 · DOI · Paper page
- Soldati, 2018, The influence of diet on anti-cancer immune responsiveness, J Transl Med, 16, 75, 10.1186/s12967-018-1448-0 · DOI · Paper page
- Bouter, 2017, Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction, Gastroenterology, 152, 1671, 10.1053/j.gastro.2016.12.048 · DOI · Paper page
- Catalano, 2017, Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child, BMJ, 356, j1, 10.1136/bmj.j1 · DOI · Paper page
- Di Renzo, 2018, Influence of FTO rs9939609 and Mediterranean diet on body composition and weight loss: a randomized clinical trial, J Transl Med, 16, 308, 10.1186/s12967-018-1680-7 · DOI · Paper page
- Lavebratt, 2012, Epigenetic regulation in obesity, Int J Obes (Lond), 36, 757, 10.1038/ijo.2011.178 · DOI
- Godfrey, 2015, The developmental environment, epigenetic biomarkers and long-term health, J Dev Orig Health Dis, 6, 399, 10.1017/S204017441500121X · DOI · Paper page
- Hamer, 2019, Association of body mass index and waist-to-hip ratio with brain structure: UK Biobank study, Neurology, 92, e594, 10.1212/WNL.0000000000006879 · DOI · Paper page
- Geha, 2017, Reorganization of brain connectivity in obesity, Hum Brain Mapp, 38, 1403, 10.1002/hbm.23462 · DOI
- Parameswaran, 2006, Altered respiratory physiology in obesity, Can Respir J, 13, 203
- Maiolo, 2001, Is altered body fat distribution responsible for reduced pulmonary function in obese type 2 diabetic adult women?, Diabetes Care, 24, 961, 10.2337/diacare.24.5.961 · doi:10.2337/diacare.24.5.961
- Bruno, 2009, Dual-energy X-ray absorptiometry analysis of body composition in patients affected by OSAS, Eur Arch Otorhinolaryngol, 266, 1285, 10.1007/s00405-008-0844-0 · DOI
- Nam, 2017, Obesity-related digestive diseases and their pathophysiology, Gut Liver, 11, 323, 10.5009/gnl15557 · DOI
- Rizzo, 2013, Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome, J Endocrinol Invest, 36, 527
- Dolin, 2018, Pregnancy in women with obesity, Obstet Gynecol Clin North Am, 45, 217, 10.1016/j.ogc.2018.01.005 · DOI
- Lause, 2017, Dermatologic manifestations of endocrine disorders, Transl Pediatr, 6, 300, 10.21037/tp.2017.09.08 · DOI · Paper page
- George, 2016, The obesity epidemic and consequences for rheumatoid arthritis care, Curr Rheumatol Rep, 18, 6, 10.1007/s11926-015-0550-z · DOI · Paper page
- Ackerman, 2017, Insights into the link between obesity and cancer, Curr Obes Rep, 6, 195, 10.1007/s13679-017-0263-x · DOI
- Kim, 2016, Obesity and cardiovascular disease: friend or foe?, Eur Heart J, 37, 3560, 10.1093/eurheartj/ehv509 · DOI · Paper page
- Kovesdy, 2017, Obesity and kidney disease: hidden consequences of the epidemic, Iran J Kidney Dis, 11, 99
- Urano, 2015, Recent genetic discoveries in osteoporosis, sarcopenia and obesity, Endocr J, 62, 475, 10.1507/endocrj.EJ15-0154 · DOI · Paper page
- Stevens, 2015, Obesity related complications in surgery, Curr Opin Otolaryngol Head Neck Surg, 23, 341, 10.1097/MOO.0000000000000194 · DOI
- Damilakis, 2010, Radiation exposure in X-ray-based imaging techniques used in osteoporosis, Eur Radiol, 20, 2707, 10.1007/s00330-010-1845-0 · DOI · Paper page
- Baim, 2005, Precision assessment and radiation safety for dualenergy xray absorptiometry: (DXA) white paper of the International Society for Clinical Densitometry, J Clin Densitom (JCD), 8
- De Lorenzo, 2006, Normal weight obese (NWO) women: an evaluation of a candidate new syndrome, Nutr Metab Cardiovasc Dis, 16, 513, 10.1016/j.numecd.2005.10.010 · DOI · Paper page
- Di Renzo, 2006, Body composition analyses in normal weight obese women, Eur Rev Med Pharmacol Sci, 10, 191
- De Lorenzo, 2016, New obesity classification criteria as a tool for bariatric surgery indication, World J Gastroenterol, 22, 681, 10.3748/wjg.v22.i2.681 · DOI · Paper page
- Ding, 2016, Lean, but not healthy: the 'metabolically obese, normal-weight' phenotype, Curr Opinions Clin Nutr Metab Care, 19, 408
- Di Renzo, 2013, Association between -308 G/A TNF-α polymorphism and appendicular skeletal muscle mass index as a marker of sarcopenia in normal weight obese syndrome, Dis Markers, 35, 615, 10.1155/2013/983424 · DOI · Paper page
- Aung, 2014, Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals, J Clin Endocrinol Metab, 99, 462, 10.1210/jc.2013-2832 · DOI · Paper page
- Kelly, 2019, Osteosarcopenic obesity: current knowledge, revised identification criteria and treatment principles, Nutrients, 11, E747, 10.3390/nu11040747 · DOI · Paper page
- Nath, 2019, The injustice of fat stigma, Bioethics, 33, 577, 10.1111/bioe.12560 · doi:10.1111/bioe.12560
- Martinez, 2018, Toxoplasma gondii infection and behavioral outcomes in humans: a systematic review, Parasitol Res, 117, 3059, 10.1007/s00436-018-6040-2 · DOI
- Alcock, 2014, Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms, Bioessays, 36, 940, 10.1002/bies.201400071 · DOI · Paper page
- Zhang, 2019, Preventable cancer burden associated with poor diet in the United States, JNCI Cancer Spectrum, pkz034, 10.1093/jncics/pkz034 · DOI · Paper page
- Lopez, 2019, Is the long-term decline in cardiovascular-disease mortality in high-income countries over? Evidence from national vital statistics, Int J Epidemiol, 10.1093/ije/dyz143 · DOI · Paper page
- Pan, 2019, Weight loss, diet composition and breast cancer incidence and outcome in postmenopausal women, Oncotarget, 10, 3088, 10.18632/oncotarget.26864 · DOI
- Brenner, 2019, Estimates of the current and future burden of cancer attributable to excess body weight and abdominal adiposity in Canada, Prev Med, 122, 49, 10.1016/j.ypmed.2019.03.014 · DOI
Cited by
Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey.
Di Renzo, L., Gualtieri, P., Pivari, F., Soldati, L., Attinà, A., Cinelli, G., Leggeri, C., Caparello, G., Barrea, L., Scerbo, F., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02399-5 · Cited by 2,234
Self-citationKropp, M., Golubnitschaja, O., Mazurakova, A., Koklesova, L., Sargheini, N., Vo, T.-T. K. S., de Clerck, E., Polivka, J., Potuznik, P., Polivka, J., et al. (2023) · EPMA Journal · doi:10.1007/s13167-023-00314-8 · Cited by 468
Dupuit, M., Maillard, F., Pereira, B., Marquezi, M. L., Lancha, A. H., & Boisseau, N. (2020) · Experimental Physiology · doi:10.1113/ep088654 · Cited by 54
“The use of BMI could also be a limitation since it does not reflect the percentage of FM or its localization, and its utilization seems less suitable with advancing age (De Lorenzo et al., 2020).”
BackgroundUnlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential
AL-Noshokaty, T. M., Abdelhamid, R., Abdelmaksoud, N. M., Khaled, A., Hossam, M., Ahmed, R., Saber, T., Khaled, S., Elshaer, S. S., & Abulsoud, A. I. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101895 · Cited by 30
“Obesity is a major public health concern because of the rising rates of sickness, disability, and mortality it has caused in recent years, as well as the rising costs associated with treating these conditions [111].”
Domagała, K., Abramowicz, A. D., Rumin, M., Tatarata, O., Osuch, M., Osuch, M., Kiełboń, A., Jaciubek, M., Luty, C., & Reklewska, Z. O. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.5125
Metadata
- Authors
- De Lorenzo, A., Romano, L., Di Renzo, L., Di Lorenzo, N., Cenname, G., & Gualtieri, P.
- Venue
- Nutrition
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 71
- Pages
- 110615
- ISSN
- 0899-9007 (ISSN-L)
- OpenAlex
- W2980456360
- Cited by
- 205
- References
- 8
- FWCI
- 36.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obesity: A preventable, treatable, but relapsing disease. https://app.cochat.ai/papers/10.1016/j.nut.2019.110615
- The paper
- De Lorenzo, A., Romano, L., Di Renzo, L., Di Lorenzo, N., Cenname, G., & Gualtieri, P. (2020). Obesity: A preventable, treatable, but relapsing disease. Nutrition. https://doi.org/10.1016/j.nut.2019.110615
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.